Xospata tablets 40mg

Xospata (gilteritinib fumarate) tablets, 40mg (YJ code: 4291053F1021, standard: 40mg 1 tablet), manufactured by Astellas Pharma, are a highly selective oral FMS-like tyrosine kinase 3 (FLT3) inhibitor used to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a FLT3 mutation. It works by inhibiting FLT3, a protein that plays a role in the growth of AML cells.